Western CDMOs say near-phrase stewardship with the pharmaceutical source chain is likely to involve them to repurpose generation traces to manufacture prescription drugs and raw materials essential to preventing the new coronavirus.Using this method, clinical evaluation in the API can commence immediately, which is important for each drug developer